| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |